Skip to main content

Advertisement

SpringerLink
Log in

An update on the pathophysiology and genetics of restless legs syndrome

  • Published:
Current Neurology and Neuroscience Reports Aims and scope Submit manuscript

Abstract

This update on restless legs syndrome (RLS) focuses on its pathophysiology, genetics, health impact, and treatment. Although symptoms are exquisitely responsive to dopaminergics, clear delineation of dopaminergic pathology has not emerged. Rather, heuristic models of alterations in spinal sensorimotor circuits and central nervous system iron deficiency are gaining more attention. Genome-wide association studies have recently identified polymorphisms in three genes with no obvious relationship to dopamine that account for 70% of the population risk for RLS. A single variant in the BTBD9 gene on chromosome 6 contributes to 50% of the population risk. Although the functions of BTBD9 remain uncertain, its biological plausibility is evidenced by its dose-dependent relationship to periodic limb movements of sleep, decrements in iron stores, and ethnic differences in RLS prevalence. RLS is also implicated in cardiovascular morbidity. Despite these advances in our knowledge, there remain unanswered questions about the pathophysiology of RLS as well as its genetics, health-related significance, and treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Stefansson H, Rye DB, Hicks A, et al.: a genetic risk factor for periodic limb movements in sleep. N Engl J Med 2007, 357:639–647.

    Article  PubMed  CAS  Google Scholar 

  2. Allen RP, Walters AS, Montplaisir J, et al.: Restless legs syndrome prevalence and impact: REST general population study. Arch Intern Med 2005, 165:1286–1292.

    Article  PubMed  Google Scholar 

  3. O’Keeffe ST, Egan D, Myers A, Redmond S: The frequency and impact of restless legs syndrome in primary care. Ir Med J 2007, 100:539–542.

    PubMed  CAS  Google Scholar 

  4. Winkelman JW, Finn L, Young T: Prevalence and correlates of restless legs syndrome symptoms in the Wisconsin Sleep Cohort. Sleep Med 2006, 7:545–552.

    Article  PubMed  Google Scholar 

  5. Picchietti D, Allen RP, Walters AS, et al.: Restless legs syndrome: prevalence and impact in children and adolescents—the Peds REST study. Pediatrics 2007, 120:253–266.

    Article  PubMed  Google Scholar 

  6. Nichols DA, Allen RP, Grauke JH, et al.: Restless legs syndrome symptoms in primary care: a prevalence study. Arch Intern Med 2003, 163:2323–2329.

    Article  PubMed  Google Scholar 

  7. Earley CJ, Allen RP, Beard JL, et al.: Insight into the pathophysiology of restless legs syndrome. J Neurosci Res 2000, 62:623–628.

    Article  PubMed  CAS  Google Scholar 

  8. Winkelman J, Chertow G, Lazarus J: Restless legs syndrome in end-stage renal disease. Am J Kidney Dis 1996, 28:372–378.

    Article  PubMed  CAS  Google Scholar 

  9. Hening WA, Caivano CK: Restless legs syndrome: a common disorder in patients with rheumatologic conditions. Semin Arthritis Rheum 2007 Oct 29 (Epub ahead of print).

  10. Merlino G, Fratticci L, Valente M, et al.: Association of restless legs syndrome in Type 2 diabetes. Sleep 2007, 30:866–871.

    PubMed  Google Scholar 

  11. Gomez-Esteban JC, Zarranz JJ, Tijero B, et al.: Restless legs syndrome in Parkinson’s disease. Mov Disord 2007, 22:1912–1916.

    Article  PubMed  Google Scholar 

  12. Trotti LM, Rye DB: Functional anatomy and treatment of RLS/PLMS emerging after spinal cord lesions [abstract]. Sleep 2007, 30:A306.

    Google Scholar 

  13. Gemignani F, Marbini A, Di Giovanni G, et al.: Charcot-Marie-Tooth disease type 2 with restless legs syndrome. Neurology 1999, 52:1064–1066.

    PubMed  CAS  Google Scholar 

  14. Abele M, Burk K, Laccone F, et al.: Restless legs syndrome in spinocerebellar ataxia types 1, 2, and 3. J Neurol 2001, 248:311–314.

    Article  PubMed  CAS  Google Scholar 

  15. Manconi M, Fabbrini M, Bonanni E, et al.: High prevalence of restless legs syndrome in multiple sclerosis. Eur J Neurol 2007, 14:534–539.

    Article  PubMed  CAS  Google Scholar 

  16. Akpinar S: Restless legs syndrome treatment with dopaminergic drugs. Clin Neuropharmacol 1987, 10:69–79.

    Article  PubMed  CAS  Google Scholar 

  17. Connor JR, Boyer PJ, Menzies SL, et al.: Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome. Neurology 2003, 61:304–309.

    PubMed  CAS  Google Scholar 

  18. Wetter TC, Eisensehr I, Trenkwalder C: Functional neuroimaging studies in restless legs syndrome. Sleep Med 2004, 5:401–406.

    Article  PubMed  Google Scholar 

  19. Godau J, Wevers AK, Gaenslen A, et al.: Sonographic abnormalities of brainstem structures in restless legs syndrome. Sleep Med 2007 Nov 15 (Epub ahead of print).

  20. Schmidauer C, Sojer M, Seppi K, et al.: Transcranial ultrasound shows nigral hypoechogenicity in restless legs syndrome. Ann Neurol 2005, 58:630–634.

    Article  PubMed  Google Scholar 

  21. Winkelmann J, Polo O, Provini F, et al.: Genetics of restless legs syndrome (RLS): state-of-the-art and future directions. Mov Disord 2007, 22:S449–S458.

    Article  PubMed  Google Scholar 

  22. Desautels A, Turecki G, Montplaisir J, et al.: Evidence for a genetic association between monoamine oxidase A and restless legs syndrome. Neurology 2002, 59:215–219.

    PubMed  CAS  Google Scholar 

  23. Rye DB, Freeman AA: Dopamine in behavioral state control. In Neurochemistry of Sleep and Wakefulness. Edited by Monti JM, Pandi-Perumal SR, Sinton CM. Cambridge: Cambridge University Press; 2008:79–221.

    Google Scholar 

  24. Garcia-Borreguero D, Larrosa D, Granizo JJ, et al.: Circadian variation in neuroendocrine response to 1-dopa in patients with restless legs syndrome. Sleep 2004, 27:669–673.

    PubMed  Google Scholar 

  25. Happe S, Bachmann CG, Helmschmied K, et al.: Growth hormone response to low-dose apomorphine in restless legs syndrome. Growth Horm IGF Res 2007, 17:323–327.

    Article  PubMed  CAS  Google Scholar 

  26. Earley CJ, Hyland K, Allen RP: Circadian changes in CSF dopaminergic measures in restless legs syndrome. Sleep Med 2006, 7:263–268.

    Article  PubMed  Google Scholar 

  27. Clemens S, Rye DB, Hochmann S: Restless legs syndrome: revisiting the dopamine hypothesis from the spinal cord perspective. Neurology 2006, 67:125–130.

    Article  PubMed  Google Scholar 

  28. Bara-Jimenez W, Aksu M, Graham B, et al.: Periodic limb movements in sleep: state-dependent excitability of the spinal flexor reflex. Neurology 2000, 54:1609–1616.

    Article  PubMed  CAS  Google Scholar 

  29. Hogl B, Frauscher B, Seppi K, et al.: Transient restless legs syndrome after spinal anesthesia. Neurology 2002, 59:1705–1707.

    PubMed  CAS  Google Scholar 

  30. Qu S, Le W, Zhang X, et al.: Locomotion is increased in A11-lesioned mice with iron deprivations: a possible animal model for restless legs syndrome. J Neuropathol Exp Neurol 2007, 66:383–388.

    Article  PubMed  CAS  Google Scholar 

  31. Trenkwalder C, Hogl B, Benes H, Kohnen R: Augmentation in restless legs syndrome is associated with low ferritin. Sleep Med 2007 Oct 5 (Epub ahead of print).

  32. Erikson KM, Jones BC, Hess EJ, et al.: Iron deficiency decreases dopamine D1 and D2 receptors in the rat brain. Pharmacol Biochem Behav 2001, 69:409–418.

    Article  PubMed  CAS  Google Scholar 

  33. Desai AV, Cherkas LF, Spector TD, Williams AJ: Genetic influences in self-reported symptoms of obstructive sleep apnoea and restless legs: a twin study. Twin Res 2004, 7:589–595.

    Article  PubMed  Google Scholar 

  34. Ondo WG, Vuong KD, Wang Q: Restless legs syndrome in monozygotic twins: clinical correlates. Neurology 2000, 55:1404–1406.

    PubMed  CAS  Google Scholar 

  35. Chen S, Ondo WG, Rao S, et al.: Genomewide linkage scan identifies a novel susceptibility locus for restless legs syndrome on chromosome 9p. Am J Hum Genet 2004, 74:876–885.

    Article  PubMed  CAS  Google Scholar 

  36. Pichler I, Hicks AA, Pramstaller PP: Restless legs syndrome: an update on genetics and future perspectives. Clin Genet 2008, 73:297–305

    PubMed  CAS  Google Scholar 

  37. Winkelmann J, Schormair B, Lichtner P, et al.: Genome-wide association study of restless legs syndrome identifies common variants in three genomic regions. Nat Genet 2007, 39:1000–1006.

    Article  PubMed  CAS  Google Scholar 

  38. Winkelman JW: Periodic limb movements in sleep—endophenotype for restless legs syndrome? N Engl J Med 2007, 357:703–705.

    Article  PubMed  CAS  Google Scholar 

  39. Kushida C, Martin M, Nikam P, et al.: Burden of restless legs syndrome on health-related quality of life. Qual Life Res 2007, 16:617–624.

    Article  PubMed  Google Scholar 

  40. Benz RL, Pressman MR, Hovick ET, Peterson DD: Potential novel predictors of mortality in end-stage renal disease patients with sleep disorders. Am J Kidney Dis 2000, 35:1221–1223.

    Article  Google Scholar 

  41. Winkelman JW, Shahar E, Sharief I, Gottlieb DJ.: Association of restless legs syndrome and cardiovascular disease in the Sleep Heart Health Study. Neurology 2008, 70:35–42.

    Article  PubMed  Google Scholar 

  42. Billars L, Hicks A, Bliwise D, et al.: Hypertension risk and PLMS in restless legs syndrome [abstract]. Sleep 2007, 30:A297–A298.

    Google Scholar 

  43. Littner MR, Kushida C, Anderson WM, et al.: Practice parameters for the dopaminergic treatment of restless legs syndrome and periodic limb movement disorder. Sleep 2004, 27:557–559.

    PubMed  Google Scholar 

  44. Happe S, Trenkwalder C: Role of dopamine receptor agonists in the treatment of restless legs syndrome. CNS Drugs 2004, 18:27–36.

    Article  PubMed  CAS  Google Scholar 

  45. Driver-Dunckley ED, Noble BN, Hentz JG, et al.: Gambling and increased sexual desire with dopaminergic medications in restless legs syndrome. Clin Neuropharmacol 2007, 30:249–255.

    Article  PubMed  CAS  Google Scholar 

  46. Garcia-Borreguero D, Allen RP, Kohnen R, et al.: Diagnostic standards for dopaminergic augmentation of restless legs syndrome. Sleep Med 2007, 8:520–530.

    Article  PubMed  Google Scholar 

  47. Earley CJ, Allen RP: Restless legs syndrome augmentation associated with tramadol. Sleep Med 2006, 7:592–593.

    Article  PubMed  Google Scholar 

  48. Garcia-Borreguero D, Allen RP, Benes H, et al.: Augmentation as a treatment complication of restless legs syndrome: concept and management. Mov Disord 2007, 22(Suppl 18):S476–S484.

    Article  PubMed  Google Scholar 

  49. Bartell S, Zallek S: Intravenous magnesium sulfate may relieve restless legs syndrome in pregnancy. J Clin Sleep Med 2006, 2:187–188.

    PubMed  Google Scholar 

  50. Pennestri MH, Montplaisir J, Colombo R, et al.: Nocturnal blood pressure changes in patients with restless legs syndrome. Neurology 2007, 68:1213–1218.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurology, Emory University School of Medicine, 101 Woodruff Circle, 6113 WMRB, Atlanta, GA, 30322, USA

    David B. Rye

Authors
  1. Lynn Marie Trotti
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Srinivas Bhadriraju
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. David B. Rye
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David B. Rye.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Trotti, L.M., Bhadriraju, S. & Rye, D.B. An update on the pathophysiology and genetics of restless legs syndrome. Curr Neurol Neurosci Rep 8, 281–287 (2008). https://doi.org/10.1007/s11910-008-0044-8

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11910-008-0044-8

Keywords

Search

Navigation